DNA-Bound Platinum Is the Major Determinant of Cisplatin Sensitivity in Head and Neck Squamous Carcinoma Cells

PURPOSE: The combination of systemic cisplatin with local and regional radiotherapy as primary treatment of head and neck squamous cell carcinoma (HNSCC) leads to cure in approximately half of the patients. The addition of cisplatin has significant effects on outcome, but despite extensive research...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Martens-de Kemp, Sanne R., Dalm, Simone U., Wijnolts, Fiona M. J., Brink, Arjen, Honeywell, Richard J., Peters, Godefridus J., Braakhuis, Boudewijn J. M., Brakenhoff, Ruud H.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Public Library of Science 2013
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3629194/
https://ncbi.nlm.nih.gov/pubmed/23613873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0061555
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια